Drugs in ATC Class D10

Up to Top Level ATC Classes

Up to D - Dermatologicals

Subclasses in ATC: D10 - ANTI-ACNE PREPARATIONS

D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE

D10B - ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE

D10 Market Analysis and Financial Projection

The global market for anti-acne preparations (ATC Class D10) is experiencing robust growth, driven by rising acne prevalence, technological innovation, and shifting consumer preferences. Below, we analyze the market dynamics and patent landscape shaping this sector.

---

Market Overview

• Global Valuation: The anti-acne cosmetics market was valued at $5.2 billion in 2024, with projections to reach $9.4–15 billion by 2030–2032, growing at a 9.1–9.7% CAGR[1][5][6][8]. Therapeutic treatments (e.g., retinoids, antibiotics) dominate, accounting for $10.08 billion in 2023 and expected to hit $15.05 billion by 2032[5][14].
• Product Segmentation:
  • Creams & lotions hold a 41.55% market share due to their dual role in hydration and medicated acne treatment[1][6].
  • Organic serums are the fastest-growing segment, fueled by demand for clean, plant-based ingredients like tea tree oil and aloe vera[4].

---

Key Growth Drivers

1. High Acne Prevalence: Affects 79–95% of adolescents in Western societies and over 50 million Americans annually, costing $4 billion in treatment[5][13].
2. R&D Investments: Innovations like nanoparticle-delivered antibiotics (e.g., Narasin) and triple-combination gels (e.g., Cabtreo) enhance efficacy[5][11].
3. Consumer Trends: Surging demand for gender-neutral products, personalized skincare, and organic formulations (e.g., Murad, La Roche-Posay)[6][8].

---

Regional Insights

• Asia Pacific: Leads with 40% market share, driven by South Korea, Japan, and Australia. High adoption of U.S.-developed products like Galderma’s Aklief cream[1][6].
• North America: Accounts for 41.4% of therapeutic sales, bolstered by FDA approvals (e.g., Twyneo Cream) and a $4 billion annual treatment expenditure[5][13].

---

Innovation Trends

• Advanced Delivery Systems:
  • Liposomal formulations improve ingredient penetration (e.g., nitric oxide liposomes)[3].
  • Nanoparticles enhance absorption (e.g., Narasin gel with 100x better efficacy)[5].
• Combination Therapies: FDA-approved blends like adapalene + benzoyl peroxide reduce inflammation and bacterial load[11][14].

---

Patent Landscape

• Key Players: Neutrogena, L’Oréal, Galderma, and Proactiv hold 15–20% market share through strategic R&D and partnerships[6].
• Patent Disputes:
  • Seagen vs. Daiichi Sankyo over peptide-antibody conjugates led to invalidated claims in 2023[2].
  • Licensing agreements (e.g., Genentech’s use of Immunogen’s emtansine technology) highlight collaborative innovation[2].
• Emerging Technologies:
  • Plant-based patents: Extracts from Aloe barbadensis and Plectranthus aliciae show antiseptic and anti-inflammatory properties[3][10].
  • AI-driven formulations: Patent filings for AI-optimized ingredient combinations surged by 33% since 2018[17].

---

Regulatory and Commercial Shifts

• Recent approvals like clascoterone cream (Winlevi) and Trifarotene reflect a focus on safer, non-antibiotic options[9][18].
• Mergers such as Honasa Consumer’s acquisition of Dr. Sheth’s emphasize dermatologist-backed branding[6].

---

Future Outlook

The sector will pivot toward bioengineered actives and microbiome-friendly formulations. Challenges include navigating patent thickets in CRISPR-based therapies[17] and balancing cost pressures amid rising demand for generics[14]. With Asia Pacific and North America driving growth, the market is poised to exceed $18.5 billion by 2032 as innovation bridges efficacy and consumer safety[14].

"The integration of nanotechnology and organic ingredients represents a paradigm shift in acne care, blending efficacy with sustainability." — Industry Analyst [3][4]

References

1. https://www.grandviewresearch.com/industry-analysis/anti-acne-cosmetics-market
2. https://www.fbrice.com.au/ip-news-insights/traversing-a-dynamic-adc-patent-landscape-2/
3. http://bulletin.mfd.org.mk/volumes/Volume%2062_2/62_2_003.pdf
4. https://www.futuremarketinsights.com/reports/anti-acne-serum-market
5. https://straitsresearch.com/report/anti-acne-treatment-market
6. https://www.gminsights.com/industry-analysis/anti-acne-cosmetics-market
7. https://patents.google.com/patent/US10201509B2/en
8. https://www.skyquestt.com/report/anti-acne-cosmetics-market
9. https://en.wikipedia.org/wiki/ATC_code_D10
10. https://patents.google.com/patent/EP3893908A1/en
11. https://www.knowledge-sourcing.com/resources/thought-articles/evolving-landscape-of-the-acne-treatment-market/
12. https://patents.google.com/patent/WO2015114666A2/en
13. https://market.us/report/acne-treatment-market/
14. https://www.thebrainyinsights.com/report/acne-medication-market-13845
15. https://atcddd.fhi.no/atc_ddd_index/?code=D10&showdescription=yes
16. https://patents.justia.com/patent/6433024
17. https://ip.com/blog/2025-patent-trends-challenges-and-innovations-shaping-the-future-of-technology/
18. https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1693490140440